Adipotide: A "Precision Scavenger" Targeting Adipose Blood Vessels
I. Product Origin
Adipotide was initially developed by scientists at MD Anderson Cancer Center in the United States, not for weight loss, but as an anti-cancer drug. Researchers were attempting to develop a peptide compound that could cut off the blood supply to tumors. During their research, they unexpectedly discovered that this compound specifically accumulated in the blood vessels of adipose tissue. This discovery shifted the research focus to obesity treatment, making it the world's first adipose tissue vascular-targeting apoptosis peptide (VTA), opening up a new pathway for weight loss by "starving" fat cells.
II. Product Parameters
Product Name: Adipotide (FTPP)
Full Sequence: CKGGRAKDC-GG-D(KLAKLAK)₂
Molecular Weight: Approximately 2416 Da
Appearance: White or off-white lyophilized powder
Purity: >95% (HPLC)
Solubility: Easily soluble in water, PBS, and physiological saline
Storage Conditions: In powder form, store in a dry, light-protected environment at -20°C; after reconstitution, it is recommended to aliquot and freeze to avoid repeated freeze-thaw cycles.
III. Core Functions
Precise Targeting: The N-terminal cyclic peptide structure (CKGGRAKDC) acts like a "navigation head," specifically recognizing and binding to the Annexin A2 receptor unique to the surface of adipose tissue vascular endothelial cells.
Inducing Apoptosis: The C-terminal pro-apoptotic domain (D(KLAKLAK)₂), upon entering the cell, targets mitochondria, disrupting their membrane potential and initiating the apoptosis program.
Severing Blood Supply: By inducing apoptosis in adipose vascular endothelial cells, the microvascular network degenerates, thereby cutting off the oxygen and nutrient supply to adipocytes.
Clearing Fat: Deprived of blood supply, adipocytes die from "starvation" and are naturally cleared by the body's immune system, achieving a dual reduction in both fat volume and quantity.
IV. Core Advantages
volutionary Mechanism of Action: Unlike traditional weight-loss drugs that suppress appetite or block fat absorption, Adipotide directly "targets" fat at the vascular level, addressing the problem at its root.
High Organ Selectivity: It acts only on white adipose tissue (especially unhealthy visceral fat), with no effect on vital organs such as muscles, heart, and brain.
**Muscle Mass Preservation:** Reduces fat without causing muscle loss, achieving the ideal effect of "fat reduction while preserving muscle."
**Improved Metabolic Health:** Effectively reduces visceral fat, the root cause of insulin resistance, thereby significantly improving metabolic indicators such as blood sugar and blood lipids, and reducing the risk of type 2 diabetes.
V. Applicable Scenarios
**Obesity and Metabolic Syndrome Research:** Serves as a cutting-edge tool to explore the pathological mechanisms and intervention strategies of obesity and its complications (such as type 2 diabetes and fatty liver).
**Refractory Visceral Fat Research:** Targets specific types of fat that are difficult to reduce through conventional methods, such as abdominal obesity and central obesity.
**Angiogenic Targeted Therapy Exploration:** Provides molecular templates and research ideas for developing novel angiogenic targeted drugs, not limited to the field of obesity.
**Oncology Research:** Based on its initial research background, continues to explore its potential to inhibit angiogenesis in specific tumor models.
VI. Precautions
For Research Use Only:** This product is currently in the clinical research stage and is for laboratory scientific research only. Human injection, clinical diagnosis, or treatment are strictly prohibited. Potential Nephrotoxicity: Early human trials have shown that high doses may have temporary effects on the kidneys; therefore, renal function must be closely monitored in any potential application.
Professional Handling: Handled by a qualified professional wearing lab coats and gloves in a fume hood.
Proper Dissolution: It is recommended to use sterile water or PBS for dissolution, mixing gently and avoiding vigorous shaking that could degrade the peptides.
VII. Success Stories
In a landmark study of rhesus monkeys, obese female rhesus monkeys treated with Adipotide for four weeks experienced an average weight loss of 11% and a 39% reduction in fat deposition. Crucially, the reduction primarily targeted high-risk visceral fat, restoring waist circumference to normal levels, and without affecting muscle mass. Significantly improved insulin sensitivity after discontinuation of the drug demonstrated its great potential in fat reduction and improved metabolic health.
Meticulous craftsmanship in peptide research, quality is the foundation of excellence.
Focusing on high-end peptide raw materials, meticulous craftsmanship ensures high quality.
Source peptide factory, high purity for greater reliability.
Hot Tags: adipotide factory wholesale, China adipotide factory wholesale manufacturers, suppliers, factory
